Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100349858C reveals solvent innovation for high-purity iohexol production reducing impurities and enhancing supply chain reliability for contrast agents.
Novel Pd-Cu catalyzed method for phenanthrene intermediates. High yield, mild conditions, scalable for pharmaceutical manufacturing supply chains.
Patent CN115286559B reveals a three-step route for Paxlovid key intermediate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112174970B reveals a scalable method for Pemetrexed Disodium using alkali-modified molecular sieves, ensuring high yield and reduced environmental impact.
Novel asymmetric acetal method for (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one synthesis. High ee%, low cost, scalable process for API manufacturing.
Patent CN106995413A reveals high-ee iridium-catalyzed hydrogenation for chiral piperazines, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN116041272B reveals a metal-free synthesis for benzoxazole derivatives using naphthylamine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105712914B details a palladium-catalyzed asymmetric thioetherification method offering high regioselectivity and mild conditions for cost reduction in pharma manufacturing.
Patent CN1281587C details a chiral phase transfer catalysis method for single isomer nitrendipine. Achieve high purity and reduced impurities for cardiovascular API manufacturing.
Patent CN100569790C reveals a high-yield 3-step route for Capecitabine intermediates using triphosgene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN113651707A reveals a high-yield, 3-step synthesis for ortho-amino trifluoroacetophenone. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN110627673B details a high-purity route for Formoterol intermediates using borane reduction, offering significant cost and supply chain advantages for API manufacturers.
Patent CN1213975C reveals efficient alkoxide catalysis for acetylenic alcohols. Reduces waste and improves supply chain reliability for pharma intermediates manufacturing globally.
Patent CN108558673B reveals a cost-effective Raney Nickel process for high-purity 2-(1-cyclohexenyl)ethylamine, optimizing dextromethorphan intermediate supply chains.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.
Advanced synthesis method for high-purity 3,4-dimethoxy benzenpropanoic acid. Enhances supply chain reliability and reduces environmental impact for pharmaceutical manufacturing.
Patent CN116514707B reveals manganese-catalyzed asymmetric hydrogenation for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability.
Patent CN116514707B reveals manganese-catalyzed asymmetric hydrogenation for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Patent CN111187264A introduces a resin-catalyzed cyclization for mirtazapine, eliminating sulfuric acid waste and simplifying purification for reliable pharmaceutical intermediate supply.
Patent CN101175715B details Rh-catalyzed hydrogenation using PhanePhos for high-purity 3,3-diarylalanine intermediates, offering scalable API synthesis solutions.